TLR3 expression was upregulated in both pristane treatment groups, especially in the pristane/poly(I:C) group, and significantly correlated with arthritis severity, suggesting that the activation of TLR3 on fibroblasts triggered by poly(I:C) causes more severe arthritis. This evidence concerns the gene TLR3 and arthritic joint disease.